These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


331 related items for PubMed ID: 20486839

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Randomized controlled trial of cyclophosphamide, warfarin and dipyridamole in idiopathic membranous glomerulonephritis.
    Murphy BF, McDonald I, Fairley KF, Kincaid-Smith PS.
    Clin Nephrol; 1992 May; 37(5):229-34. PubMed ID: 1606772
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Benefit and cost from the long-term use of cyclosporine-A in idiopathic membranous nephropathy.
    Kalliakmani P, Koutroulia E, Sotsiou F, Vlachojannis JG, Goumenos DS.
    Nephrology (Carlton); 2010 Dec; 15(8):762-7. PubMed ID: 21175962
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.
    du Buf-Vereijken PW, Branten AJ, Wetzels JF.
    Am J Kidney Dis; 2005 Dec; 46(6):1012-29. PubMed ID: 16310567
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
    Liang Q, Li H, Xie X, Qu F, Li X, Chen J.
    Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
    [Abstract] [Full Text] [Related]

  • 31. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 32. [A controlled clinical trial of Consupren versus cyclophosphamide in chronic glomerulonephritis].
    Matl I, Matousovic K, Herout V, Konecný K, Kovác A, Rychlík I, Sobotová D, Roland R, Zdichyncová I, Lánská V.
    Cas Lek Cesk; 1997 Feb 12; 136(4):120-3. PubMed ID: 9221182
    [Abstract] [Full Text] [Related]

  • 33. Treatment-related changes in urinary excretion of high and low molecular weight proteins in patients with idiopathic membranous nephropathy and renal insufficiency.
    du Buf-Vereijken PW, Wetzels JF.
    Nephrol Dial Transplant; 2006 Feb 12; 21(2):389-96. PubMed ID: 16234291
    [Abstract] [Full Text] [Related]

  • 34. A pilot study of low-dose fludarabine in membranous nephropathy refractory to therapy.
    Boumpas DT, Tassiulas IO, Fleisher TA, Vaughan E, Piscitelli S, Kim Y, Pucino F, Balow JE, Austin HA.
    Clin Nephrol; 1999 Aug 12; 52(2):67-75. PubMed ID: 10480216
    [Abstract] [Full Text] [Related]

  • 35. The therapy of idiopathic membranous glomerulonephritis.
    Glassock RJ.
    Semin Nephrol; 1991 Mar 12; 11(2):138-47. PubMed ID: 2034923
    [Abstract] [Full Text] [Related]

  • 36. [Primary chronic glomerulonephritis with nephrotic syndrome. Treatment with prednisone and cyclophosphamide].
    Knotková V, Nĕmecek K, Tarayeva IE, Krasnova TN.
    Vnitr Lek; 1993 Dec 12; 39(12):1157-63. PubMed ID: 8310664
    [Abstract] [Full Text] [Related]

  • 37. Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone.
    Eriguchi M, Oka H, Mizobuchi T, Kamimura T, Sugawara K, Harada A.
    Nephrol Dial Transplant; 2009 Oct 12; 24(10):3082-8. PubMed ID: 19465558
    [Abstract] [Full Text] [Related]

  • 38. Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults.
    Ponticelli C, Passerini P.
    Clin Nephrol; 1991 Oct 12; 35 Suppl 1():S16-21. PubMed ID: 1860261
    [Abstract] [Full Text] [Related]

  • 39. [Effects of cyclophosphamide on the length of remission in patients suffering from glomerulonephritis with nephrotic syndrome].
    Duman VL, Shkerina LI, Shilov EM.
    Klin Med (Mosk); 2005 Oct 12; 83(10):48-50. PubMed ID: 16320847
    [Abstract] [Full Text] [Related]

  • 40. [Membranous kidney diseases in adults].
    Sobarzo Toro M, Vilches A.
    Medicina (B Aires); 2004 Oct 12; 64(1):59-65. PubMed ID: 15034960
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.